Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 69 articles:
HTML format
Text format



Single Articles


    October 2017
  1. LEMOINNE S, Marteau P
    Gut microbial profile in primary biliary cholangitis: Towards bioindicators.
    Clin Res Hepatol Gastroenterol. 2017;41:507-508.
    PubMed     Text format    


    September 2017
  2. MURATORI P, Muratori L
    Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2017;41:e47.
    PubMed     Text format    


    March 2017
  3. JAMSHIDZADEH A, Heidari R, Latifpour Z, Ommati MM, et al
    Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats.
    Clin Res Hepatol Gastroenterol. 2017 Mar 7. pii: S2210-7401(17)30009.
    PubMed     Text format     Abstract available


  4. CHEN Y, Li L, Qian X, Ge Y, et al
    High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017;41:190-196.
    PubMed     Text format     Abstract available


  5. BAO S, Zheng J, Li N, Huang C, et al
    Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage.
    Clin Res Hepatol Gastroenterol. 2017;41:147-155.
    PubMed     Text format     Abstract available


  6. KANG HG, Wang BZ, Zhang J, Liu MR, et al
    Combination of temsirolimus and adriamycin exhibits an enhanced antitumor effect in hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017;41:197-203.
    PubMed     Text format     Abstract available


  7. HUANG R, Zhang Q, Huang Q, Zu M, et al
    Number and function of circulating endothelial progenitor cells in patients with primary Budd-Chiari syndrome.
    Clin Res Hepatol Gastroenterol. 2017;41:139-146.
    PubMed     Text format     Abstract available


  8. MA W, Wang H, Jing W, Zhou F, et al
    Downregulation of long non-coding RNAs JPX and XIST is associated with the prognosis of hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017;41:163-170.
    PubMed     Text format     Abstract available


    February 2017
  9. LI K, Liu H, Guo T
    Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients.
    Clin Res Hepatol Gastroenterol. 2017 Feb 3. pii: S2210-7401(17)30003.
    PubMed     Text format     Abstract available


  10. MOTAMED N, Rabiee B, Poustchi H, Dehestani B, et al
    Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Clin Res Hepatol Gastroenterol. 2017;41:31-38.
    PubMed     Text format     Abstract available


  11. SHIN JH, Jung JH
    Non-alcoholic fatty liver disease and flavonoids: Current perspectives.
    Clin Res Hepatol Gastroenterol. 2017;41:17-24.
    PubMed     Text format     Abstract available


  12. MANENTI A, Roncati L, Simonini E, Farinetti A, et al
    HCC chemoembolization: Still a challenge.
    Clin Res Hepatol Gastroenterol. 2017;41:e14-e16.
    PubMed     Text format    


  13. TAS A, Kara B, Yilmaz C, Suat Yalcin M, et al
    Fulminant Budd-Chiari syndrome due to ecstasy.
    Clin Res Hepatol Gastroenterol. 2017;41:e12-e13.
    PubMed     Text format    


  14. CHEN P, Yuan P, Chen B, Sun J, et al
    Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017;41:75-85.
    PubMed     Text format     Abstract available


  15. WATSON A, Bul V, Staudacher J, Carroll R, et al
    The predictors of mortality and secular changes in management strategies in emphysematous gastritis.
    Clin Res Hepatol Gastroenterol. 2017;41:e1-e7.
    PubMed     Text format     Abstract available


    December 2016
  16. ZHENG L, Qin J, Sun L, Gui L, et al
    Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension.
    Clin Res Hepatol Gastroenterol. 2016 Dec 30. pii: S2210-7401(16)30203.
    PubMed     Text format     Abstract available


    November 2016
  17. XU SL, Zhang YC, Wang GY, Yang Q, et al
    Survival analysis of sirolimus-based immunosuppression in liver transplantation in patients with hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2016 Nov 4. pii: S2210-7401(16)30046.
    PubMed     Text format     Abstract available


    July 2016
  18. TAS A, Olmez S, Yalcin MS
    A rare cause of elevated alpha fetoprotein in patient with cirrhosis.
    Clin Res Hepatol Gastroenterol. 2016 Jul 5. pii: S2210-7401(16)30084.
    PubMed     Text format    


    May 2016
  19. WOSIEWICZ P, Zorniak M, Hartleb M, Baranski K, et al
    Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.
    Clin Res Hepatol Gastroenterol. 2016 May 5. pii: S2210-7401(16)30048.
    PubMed     Text format     Abstract available


    April 2016
  20. LIU L, Zhang C, Hu Y, Zhou L, et al
    Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation.
    Clin Res Hepatol Gastroenterol. 2016 Apr 6. pii: S2210-7401(16)30038.
    PubMed     Text format     Abstract available


  21. DIXON PH, Williamson C
    The pathophysiology of intrahepatic cholestasis of pregnancy.
    Clin Res Hepatol Gastroenterol. 2016;40:141-53.
    PubMed     Text format     Abstract available


  22. GALLETTO PREGLIASCO A, Wendum D, Goumard C, Arrive L, et al
    Hepatic epithelioid hemangioendothelioma.
    Clin Res Hepatol Gastroenterol. 2016;40:136-8.
    PubMed     Text format    


  23. ERLINGER S
    Intrahepatic cholestasis of pregnancy: A risk factor for cancer, autoimmune and cardiovascular diseases?
    Clin Res Hepatol Gastroenterol. 2016;40:139-40.
    PubMed     Text format     Abstract available


  24. XU H, Wang H, Zhao N, Zhou F, et al
    Lipid deposition in liver cells: The influence of short form augmenter of liver regeneration.
    Clin Res Hepatol Gastroenterol. 2016;40:186-94.
    PubMed     Text format     Abstract available


  25. LIU WR, Jin L, Tian MX, Jiang XF, et al
    Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2016;40:169-78.
    PubMed     Text format     Abstract available


    February 2016
  26. ISMAIL H, Broniszczak D, Markiewicz-Kijewska M, Ciopinski M, et al
    Metastases of pancreatic neuroendocrine tumor to the liver as extremely rare indication for liver transplantation in children. Case report and review of the literature.
    Clin Res Hepatol Gastroenterol. 2016 Feb 2. pii: S2210-7401(15)00292.
    PubMed     Text format     Abstract available


  27. BALLET F
    FXR: Big fish or small fry for drug-induced liver injury?
    Clin Res Hepatol Gastroenterol. 2016;40:6-8.
    PubMed     Text format     Abstract available


  28. GILBERT A, Doussot A, Lagoutte N, Facy O, et al
    Combined zinc sulphate and NSAID-induced gastric ulcer perforation in Wilson disease: A case report.
    Clin Res Hepatol Gastroenterol. 2016;40:e11-2.
    PubMed     Text format    


  29. POUPON R, Cazals-Hatem D, Arrive L
    Fenofibrate-induced massive regression of mutiple inflammatory hepatocellular adenoma.
    Clin Res Hepatol Gastroenterol. 2016;40:e1-3.
    PubMed     Text format     Abstract available


  30. NAULT JC, Zucman-Rossi J
    TERT promoter mutations in primary liver tumors.
    Clin Res Hepatol Gastroenterol. 2016;40:9-14.
    PubMed     Text format     Abstract available


  31. WANG YL, Chen CM, Wang XM, Wang L, et al
    Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2016;40:51-6.
    PubMed     Text format     Abstract available


    November 2015
  32. RASZEJA-WYSZOMIRSKA J, Wunsch E, Krawczyk M, Rigopoulou EI, et al
    Assessment of health related quality of life in polish patients with primary biliary cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Nov 24. pii: S2210-7401(15)00260.
    PubMed     Text format     Abstract available


    October 2015
  33. HASTIER A, Patouraux S, Canivet CM, Lebeaupin C, et al
    Nonalcoholic steatohepatitis cirrhosis and type 1 refractory celiac disease: More than a fortuitous association?
    Clin Res Hepatol Gastroenterol. 2015 Oct 29. pii: S2210-7401(15)00249.
    PubMed     Text format    


  34. GAO PJ, Gao J, Li Z, Hu ZP, et al
    Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.
    Clin Res Hepatol Gastroenterol. 2015 Oct 20. pii: S2210-7401(15)00121.
    PubMed     Text format     Abstract available


  35. GALMICHE A, Diouf M, Barbare JC
    The endless SEARCH for a better medical treatment of advanced hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2015;39:535-7.
    PubMed     Text format    


  36. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.
    Clin Res Hepatol Gastroenterol. 2015;39:e57-9.
    PubMed     Text format    


    September 2015
  37. HU Z, Qian Z, Wu J, Zhou J, et al
    Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.
    Clin Res Hepatol Gastroenterol. 2015 Sep 14. pii: S2210-7401(15)00208.
    PubMed     Text format     Abstract available


    July 2015
  38. MACHADO MV, Cortez-Pinto H
    Proangiogenic factors in the development of HCC in alcoholic cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Jul 17. pii: S2210-7401(15)00131.
    PubMed     Text format     Abstract available


  39. MARRONI CA
    Management of alcohol recurrence before and after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2015 Jul 17. pii: S2210-7401(15)00135.
    PubMed     Text format     Abstract available


  40. ZHU W, Chang-Li L, Mao-Yao W, Li Y, et al
    Persistent abnormal liver function tests may predict development of cirrhosis in chronic hepatic graft-versus-host disease.
    Clin Res Hepatol Gastroenterol. 2015 Jul 13. pii: S2210-7401(15)00143.
    PubMed     Text format    


    June 2015
  41. PERNOT S, Artru P, Mithieux F, Marsot J, et al
    Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 tri
    Clin Res Hepatol Gastroenterol. 2015 Jun 30. pii: S2210-7401(15)00134.
    PubMed     Text format     Abstract available


  42. KRANSDORF LN, Millstine D, Smith ML, Aqel BA, et al
    Hepatic glycogen deposition in a patient with anorexia nervosa and persistently abnormal transaminase levels.
    Clin Res Hepatol Gastroenterol. 2015 Jun 8. pii: S2210-7401(15)00088.
    PubMed     Text format     Abstract available


  43. TAN YL, Bai ZG, Zou WL, Ma XM, et al
    miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2015;39:359-65.
    PubMed     Text format     Abstract available


  44. WANG SB, Wu HB, Wang QS, Zhou WL, et al
    Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2015;39:324-30.
    PubMed     Text format     Abstract available


  45. ALBERTI N, Castain C, Frulio N, Crombe A, et al
    Liver metastases within focal nodular hyperplasias.
    Clin Res Hepatol Gastroenterol. 2015;39:280-1.
    PubMed     Text format    


    May 2015
  46. QI X, Su C, Ren W, Yang M, et al
    Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature.
    Clin Res Hepatol Gastroenterol. 2015 May 5. pii: S2210-7401(15)00081.
    PubMed     Text format     Abstract available


    April 2015
  47. GRIGORIAN AY, Mardini HE, Corpechot C, Poupon R, et al
    Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2015 Apr 13. pii: S2210-7401(15)00077.
    PubMed     Text format     Abstract available


  48. MANENTI A, Pavesi E, Farinetti A, Colasanto D, et al
    For a better morpho-dynamic evaluation of the portal system in cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Apr 7. pii: S2210-7401(15)00045.
    PubMed     Text format    


  49. EYRAUD D
    Clinics and Research in Hepatology and Gastroenterology. Editorial.
    Clin Res Hepatol Gastroenterol. 2015;39:151-2.
    PubMed     Text format    


  50. MA JQ, Ding J, Zhang L, Liu CM, et al
    Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway.
    Clin Res Hepatol Gastroenterol. 2015;39:188-97.
    PubMed     Text format     Abstract available


  51. CAO S, Yan B, Lu Y, Zhang G, et al
    Methylation of promoter and expression silencing of GPX3 gene in hepatocellular carcinoma tissue.
    Clin Res Hepatol Gastroenterol. 2015;39:198-204.
    PubMed     Text format     Abstract available


  52. VANCLOOSTER A, Cassiman D, Van Steenbergen W, Swinkels DW, et al
    The quality of hereditary haemochromatosis guidelines: a comparative analysis.
    Clin Res Hepatol Gastroenterol. 2015;39:205-14.
    PubMed     Text format     Abstract available


  53. BLANC JF, Frulio N, Chiche L, Sempoux C, et al
    Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.
    Clin Res Hepatol Gastroenterol. 2015;39:180-7.
    PubMed     Text format     Abstract available


  54. CHEN M, Zheng T, Han S, Zhang L, et al
    A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients.
    Clin Res Hepatol Gastroenterol. 2015;39:215-21.
    PubMed     Text format     Abstract available


  55. ALBERTI N, Castain C, Crombe A, Frulio N, et al
    Steatotic hepatocellular adenomas with different phenotypic subtypes: a case report.
    Clin Res Hepatol Gastroenterol. 2015;39:e17-22.
    PubMed     Text format     Abstract available


  56. BRUSTIA R, Perdigao F, Colignon N, Scatton O, et al
    Hydatid biliocystic fistula-induced cholestasis.
    Clin Res Hepatol Gastroenterol. 2015;39:153-4.
    PubMed     Text format    


    February 2015
  57. LIBERAL R, Grant CR, Baptista R, Macedo G, et al
    "Porto-pulmonary hypertension: A comprehensive review"
    Clin Res Hepatol Gastroenterol. 2015 Feb 5. pii: S2210-7401(15)00006.
    PubMed     Text format     Abstract available


  58. JIANG M, Wang Z, Tsauo J, Li X, et al
    Basal ganglia hyperintensity may be a marker of hepatic encephalopathy secondary to portosystemic shunting.
    Clin Res Hepatol Gastroenterol. 2015;39:e5-6.
    PubMed     Text format    


  59. LUO AJ, Wang FZ, Luo D, Hu DH, et al
    Consumption of vegetables may reduce the risk of liver cancer: results from a meta-analysis of case-control and cohort studies.
    Clin Res Hepatol Gastroenterol. 2015;39:45-51.
    PubMed     Text format     Abstract available


  60. SUN H, Hou J, Shi W, Zhang L, et al
    Estrogen receptor 1 (ESR1) genetic variations in cancer risk: a systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2015;39:127-35.
    PubMed     Text format     Abstract available


  61. BEKCI T, Ozdemir M, Mehmet Selim N, Danaci M, et al
    Chemoresponsive liver hemangioma in a patient with metastatic malignant teratoma.
    Clin Res Hepatol Gastroenterol. 2015;39:1-2.
    PubMed     Text format    


    January 2015
  62. LI H, Li B, Wei Y, Yan L, et al
    Preoperative transarterial chemoembolization does not increase hepatic artery complications after liver transplantation: A single center 12-year experience.
    Clin Res Hepatol Gastroenterol. 2015 Jan 23. pii: S2210-7401(14)00300.
    PubMed     Text format     Abstract available


  63. MAO W, Hu Y, Lou Y, Dou J, et al
    Immature platelet fraction values predict recovery of platelet counts following liver transplantation.
    Clin Res Hepatol Gastroenterol. 2015 Jan 12. pii: S2210-7401(14)00294.
    PubMed     Text format     Abstract available


    November 2014
  64. TAM N, Zhang C, Lin J, Wu C, et al
    Simultaneous pancreas and kidney transplantation for liver transplant recipients with diabetes and uremia.
    Clin Res Hepatol Gastroenterol. 2014 Nov 4. pii: S2210-7401(14)00244.
    PubMed     Text format     Abstract available


    September 2014
  65. MUTHU V, Das A, Bal A, Agarwal R, et al
    Severe cholestasis and hepatic dysfunction in a case of fatal paraquat poisoning.
    Clin Res Hepatol Gastroenterol. 2014 Sep 2. pii: S2210-7401(14)00176.
    PubMed     Text format    


    August 2014
  66. QU W, Zhu ZJ, Sun LY, Wei L, et al
    Salvage liver transplantation for hepatocellular carcinoma recurrence after primary liver resection.
    Clin Res Hepatol Gastroenterol. 2014 Aug 20. pii: S2210-7401(14)00169.
    PubMed     Text format     Abstract available


  67. VUACHET D, Cervoni JP, Vuitton L, Weil D, et al
    Improved survival of cirrhotic patients with variceal bleeding over the decade 2000-2010.
    Clin Res Hepatol Gastroenterol. 2014 Aug 18. pii: S2210-7401(14)00168.
    PubMed     Text format     Abstract available


  68. UNTAS A, Boujut E, Corpechot C, Zenasni F, et al
    Quality of life and illness perception in primary biliary cirrhosis: A controlled cross-sectional study.
    Clin Res Hepatol Gastroenterol. 2014 Aug 11. pii: S2210-7401(14)00165.
    PubMed     Text format     Abstract available


    July 2014
  69. AUBE C
    Imaging modalities for the diagnosis of hepatic fibrosis and cirrhosis.
    Clin Res Hepatol Gastroenterol. 2014 Jul 15. pii: S2210-7401(14)00151.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: